HEADER HYDROLASE 12-DEC-14 4RXX TITLE CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN UBIQUITIN SPECIFIC TITLE 2 PROTEASE 38 COMPND MOL_ID: 1; COMPND 2 MOLECULE: UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 38; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN (UNP RESIDUES 1-424); COMPND 5 SYNONYM: DEUBIQUITINATING ENZYME 38, HP43.8KD, UBIQUITIN THIOESTERASE COMPND 6 38, UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 38; COMPND 7 EC: 3.4.19.12; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: USP38, KIAA1891; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)-V2R PRARE2; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PNIC-CH KEYWDS HYDROLASE, UBIQUITIN-SPECIFIC PROTEASE, HEAT-REPEAT, STRUCTURAL KEYWDS 2 GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC EXPDTA X-RAY DIFFRACTION AUTHOR A.DONG,L.SHEN,J.HU,Y.LI,W.TEMPEL,C.BOUNTRA,C.H.ARROWSMITH, AUTHOR 2 A.M.EDWARDS,Y.TONG,STRUCTURAL GENOMICS CONSORTIUM (SGC) REVDAT 3 16-OCT-24 4RXX 1 REMARK SEQADV LINK REVDAT 2 22-NOV-17 4RXX 1 REMARK REVDAT 1 21-JAN-15 4RXX 0 JRNL AUTH L.SHEN,A.DONG,J.HU,Y.LI,W.TEMPEL,C.BOUNTRA,C.H.ARROWSMITH, JRNL AUTH 2 A.M.EDWARDS,Y.TONG JRNL TITL CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN JRNL TITL 2 UBIQUITIN SPECIFIC PROTEASE 38 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.06 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0073 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.06 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 35715 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1137 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.06 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.11 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2583 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.26 REMARK 3 BIN R VALUE (WORKING SET) : 0.2600 REMARK 3 BIN FREE R VALUE SET COUNT : 69 REMARK 3 BIN FREE R VALUE : 0.2890 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3375 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 10 REMARK 3 SOLVENT ATOMS : 221 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.33000 REMARK 3 B22 (A**2) : -0.60000 REMARK 3 B33 (A**2) : -1.72000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.164 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.161 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.119 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.505 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.927 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3526 ; 0.010 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3406 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4816 ; 1.324 ; 1.971 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7842 ; 0.783 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 443 ; 4.487 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 146 ;37.569 ;23.973 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 570 ;13.150 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;22.308 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 567 ; 0.081 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3937 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 803 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1736 ; 1.904 ; 3.395 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1735 ; 1.902 ; 3.393 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2179 ; 2.686 ; 5.078 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4RXX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-DEC-14. REMARK 100 THE DEPOSITION ID IS D_1000087932. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-NOV-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97932 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37072 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.060 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 9.700 REMARK 200 R MERGE (I) : 0.12700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.06 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.3 REMARK 200 DATA REDUNDANCY IN SHELL : 5.90 REMARK 200 R MERGE FOR SHELL (I) : 0.82000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SOLVE, RESOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.92 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SAMPLE WAS FIRST MIXED HAMPTON REMARK 280 RESEARCH ADDITIVE SCREEN H03 40% IN 10:1 (V/V) PROTEIN:1,3- REMARK 280 PROPANEDIOL RATIO, THEN SET UP WITH 15% PEG8000, 0.2 M MGCL2, REMARK 280 0.1 M HEPES, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 291K, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.99250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 67.64050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.01950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 67.64050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.99250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 51.01950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 427 REMARK 465 HIS A 428 REMARK 465 HIS A 429 REMARK 465 HIS A 430 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 3 CE NZ REMARK 470 GLN A 59 CD OE1 NE2 REMARK 470 GLU A 66 CD OE1 OE2 REMARK 470 LYS A 99 CE NZ REMARK 470 LYS A 162 CG CD CE NZ REMARK 470 VAL A 181 CG1 CG2 REMARK 470 GLN A 184 CD OE1 NE2 REMARK 470 ARG A 186 CD NE CZ NH1 NH2 REMARK 470 GLU A 209 CG CD OE1 OE2 REMARK 470 LYS A 263 CD CE NZ REMARK 470 LEU A 325 CG CD1 CD2 REMARK 470 GLU A 396 CD OE1 OE2 REMARK 470 LYS A 403 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 30 37.01 -87.44 REMARK 500 HIS A 94 -118.03 55.69 REMARK 500 ARG A 138 60.78 60.65 REMARK 500 LEU A 282 58.49 -109.23 REMARK 500 ALA A 283 46.72 -98.29 REMARK 500 TYR A 388 57.85 -113.50 REMARK 500 GLN A 419 136.87 -32.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 502 DBREF 4RXX A 1 424 UNP Q8NB14 UBP38_HUMAN 1 424 SEQADV 4RXX HIS A 425 UNP Q8NB14 EXPRESSION TAG SEQADV 4RXX HIS A 426 UNP Q8NB14 EXPRESSION TAG SEQADV 4RXX HIS A 427 UNP Q8NB14 EXPRESSION TAG SEQADV 4RXX HIS A 428 UNP Q8NB14 EXPRESSION TAG SEQADV 4RXX HIS A 429 UNP Q8NB14 EXPRESSION TAG SEQADV 4RXX HIS A 430 UNP Q8NB14 EXPRESSION TAG SEQRES 1 A 430 MSE ASP LYS ILE LEU GLU GLY LEU VAL SER SER SER HIS SEQRES 2 A 430 PRO LEU PRO LEU LYS ARG VAL ILE VAL ARG LYS VAL VAL SEQRES 3 A 430 GLU SER ALA GLU HIS TRP LEU ASP GLU ALA GLN CYS GLU SEQRES 4 A 430 ALA MSE PHE ASP LEU THR THR ARG LEU ILE LEU GLU GLY SEQRES 5 A 430 GLN ASP PRO PHE GLN ARG GLN VAL GLY HIS GLN VAL LEU SEQRES 6 A 430 GLU ALA TYR ALA ARG TYR HIS ARG PRO GLU PHE GLU SER SEQRES 7 A 430 PHE PHE ASN LYS THR PHE VAL LEU GLY LEU LEU HIS GLN SEQRES 8 A 430 GLY TYR HIS SER LEU ASP ARG LYS ASP VAL ALA ILE LEU SEQRES 9 A 430 ASP TYR ILE HIS ASN GLY LEU LYS LEU ILE MSE SER CYS SEQRES 10 A 430 PRO SER VAL LEU ASP LEU PHE SER LEU LEU GLN VAL GLU SEQRES 11 A 430 VAL LEU ARG MSE VAL CYS GLU ARG PRO GLU PRO GLN LEU SEQRES 12 A 430 CYS ALA ARG LEU SER ASP LEU LEU THR ASP PHE VAL GLN SEQRES 13 A 430 CYS ILE PRO LYS GLY LYS LEU SER ILE THR PHE CYS GLN SEQRES 14 A 430 GLN LEU VAL ARG THR ILE GLY HIS PHE GLN CYS VAL SER SEQRES 15 A 430 THR GLN GLU ARG GLU LEU ARG GLU TYR VAL SER GLN VAL SEQRES 16 A 430 THR LYS VAL SER ASN LEU LEU GLN ASN ILE TRP LYS ALA SEQRES 17 A 430 GLU PRO ALA THR LEU LEU PRO SER LEU GLN GLU VAL PHE SEQRES 18 A 430 ALA SER ILE SER SER THR ASP ALA SER PHE GLU PRO SER SEQRES 19 A 430 VAL ALA LEU ALA SER LEU VAL GLN HIS ILE PRO LEU GLN SEQRES 20 A 430 MSE ILE THR VAL LEU ILE ARG SER LEU THR THR ASP PRO SEQRES 21 A 430 ASN VAL LYS ASP ALA SER MSE THR GLN ALA LEU CYS ARG SEQRES 22 A 430 MSE ILE ASP TRP LEU SER TRP PRO LEU ALA GLN HIS VAL SEQRES 23 A 430 ASP THR TRP VAL ILE ALA LEU LEU LYS GLY LEU ALA ALA SEQRES 24 A 430 VAL GLN LYS PHE THR ILE LEU ILE ASP VAL THR LEU LEU SEQRES 25 A 430 LYS ILE GLU LEU VAL PHE ASN ARG LEU TRP PHE PRO LEU SEQRES 26 A 430 VAL ARG PRO GLY ALA LEU ALA VAL LEU SER HIS MSE LEU SEQRES 27 A 430 LEU SER PHE GLN HIS SER PRO GLU ALA PHE HIS LEU ILE SEQRES 28 A 430 VAL PRO HIS VAL VAL ASN LEU VAL HIS SER PHE LYS ASN SEQRES 29 A 430 ASP GLY LEU PRO SER SER THR ALA PHE LEU VAL GLN LEU SEQRES 30 A 430 THR GLU LEU ILE HIS CYS MSE MSE TYR HIS TYR SER GLY SEQRES 31 A 430 PHE PRO ASP LEU TYR GLU PRO ILE LEU GLU ALA ILE LYS SEQRES 32 A 430 ASP PHE PRO LYS PRO SER GLU GLU LYS ILE LYS LEU ILE SEQRES 33 A 430 LEU ASN GLN SER ALA TRP THR SER HIS HIS HIS HIS HIS SEQRES 34 A 430 HIS MODRES 4RXX MSE A 1 MET SELENOMETHIONINE MODRES 4RXX MSE A 41 MET SELENOMETHIONINE MODRES 4RXX MSE A 115 MET SELENOMETHIONINE MODRES 4RXX MSE A 134 MET SELENOMETHIONINE MODRES 4RXX MSE A 248 MET SELENOMETHIONINE MODRES 4RXX MSE A 267 MET SELENOMETHIONINE MODRES 4RXX MSE A 274 MET SELENOMETHIONINE MODRES 4RXX MSE A 337 MET SELENOMETHIONINE MODRES 4RXX MSE A 384 MET SELENOMETHIONINE MODRES 4RXX MSE A 385 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 41 8 HET MSE A 115 8 HET MSE A 134 16 HET MSE A 248 8 HET MSE A 267 8 HET MSE A 274 8 HET MSE A 337 8 HET MSE A 384 8 HET MSE A 385 8 HET CL A 501 1 HET EDO A 502 4 HET UNX A 503 1 HET UNX A 504 1 HET UNX A 505 1 HET UNX A 506 1 HET UNX A 507 1 HETNAM MSE SELENOMETHIONINE HETNAM CL CHLORIDE ION HETNAM EDO 1,2-ETHANEDIOL HETNAM UNX UNKNOWN ATOM OR ION HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 10(C5 H11 N O2 SE) FORMUL 2 CL CL 1- FORMUL 3 EDO C2 H6 O2 FORMUL 4 UNX 5(X) FORMUL 9 HOH *221(H2 O) HELIX 1 1 MSE A 1 SER A 10 1 10 HELIX 2 2 PRO A 14 ALA A 29 1 16 HELIX 3 3 ASP A 34 GLY A 52 1 19 HELIX 4 4 ASP A 54 HIS A 72 1 19 HELIX 5 5 HIS A 72 PHE A 80 1 9 HELIX 6 6 ASN A 81 GLY A 92 1 12 HELIX 7 7 ASP A 100 MSE A 115 1 16 HELIX 8 8 SER A 119 GLU A 137 1 19 HELIX 9 9 GLU A 140 PHE A 154 1 15 HELIX 10 10 VAL A 155 ILE A 158 5 4 HELIX 11 11 GLY A 161 GLY A 176 1 16 HELIX 12 12 GLN A 184 GLU A 209 1 26 HELIX 13 13 THR A 212 SER A 225 1 14 HELIX 14 14 SER A 234 VAL A 241 5 8 HELIX 15 15 PRO A 245 ASP A 259 1 15 HELIX 16 16 LYS A 263 TRP A 277 1 15 HELIX 17 17 LEU A 278 TRP A 280 5 3 HELIX 18 18 HIS A 285 VAL A 300 1 16 HELIX 19 19 LYS A 302 ARG A 320 1 19 HELIX 20 20 LEU A 321 PHE A 323 5 3 HELIX 21 21 VAL A 326 PHE A 341 1 16 HELIX 22 22 PRO A 345 VAL A 352 1 8 HELIX 23 23 HIS A 354 LYS A 363 1 10 HELIX 24 24 LEU A 367 TYR A 388 1 22 HELIX 25 25 PHE A 391 LYS A 403 1 13 HELIX 26 26 SER A 409 LEU A 417 1 9 LINK C MSE A 1 N ASP A 2 1555 1555 1.33 LINK C ALA A 40 N MSE A 41 1555 1555 1.33 LINK C MSE A 41 N PHE A 42 1555 1555 1.34 LINK C ILE A 114 N MSE A 115 1555 1555 1.34 LINK C MSE A 115 N SER A 116 1555 1555 1.33 LINK C ARG A 133 N AMSE A 134 1555 1555 1.33 LINK C ARG A 133 N BMSE A 134 1555 1555 1.33 LINK C AMSE A 134 N VAL A 135 1555 1555 1.33 LINK C BMSE A 134 N VAL A 135 1555 1555 1.33 LINK C GLN A 247 N MSE A 248 1555 1555 1.33 LINK C MSE A 248 N ILE A 249 1555 1555 1.33 LINK C SER A 266 N MSE A 267 1555 1555 1.32 LINK C MSE A 267 N THR A 268 1555 1555 1.33 LINK C ARG A 273 N MSE A 274 1555 1555 1.33 LINK C MSE A 274 N ILE A 275 1555 1555 1.32 LINK C HIS A 336 N MSE A 337 1555 1555 1.32 LINK C MSE A 337 N LEU A 338 1555 1555 1.32 LINK C CYS A 383 N MSE A 384 1555 1555 1.33 LINK C MSE A 384 N MSE A 385 1555 1555 1.32 LINK C MSE A 385 N TYR A 386 1555 1555 1.33 SITE 1 AC1 3 GLY A 390 PHE A 391 TYR A 395 SITE 1 AC2 6 HIS A 360 SER A 361 PHE A 362 LYS A 363 SITE 2 AC2 6 ASN A 364 ASP A 365 CRYST1 41.985 102.039 135.281 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023818 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009800 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007392 0.00000 HETATM 1 N MSE A 1 32.323 68.789 98.611 1.00 38.12 N HETATM 2 CA MSE A 1 32.178 69.690 97.446 1.00 36.93 C HETATM 3 C MSE A 1 30.941 69.419 96.644 1.00 35.19 C HETATM 4 O MSE A 1 30.552 70.252 95.846 1.00 33.24 O HETATM 5 CB MSE A 1 33.411 69.576 96.556 1.00 38.08 C HETATM 6 CG MSE A 1 34.670 70.056 97.275 1.00 41.74 C HETATM 7 SE MSE A 1 34.473 71.979 97.775 1.00 55.36 SE HETATM 8 CE MSE A 1 35.111 72.848 96.100 1.00 41.46 C